MRKR
Marker Therapeutics Inc
Clinical-stage immuno-oncology company developing T cell-based immunotherapies
CUSIP: 57055L206HealthcareUS1 holder
Total Value
$22.4K
Total Shares
15.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Matrix Asset Advisors
$22.4K15.0K sharesUnchanged